Sudarshan Pharma — 360° view

Sudarshan Pharma, a company in the Specialty Chemicals industry, reported revenue of ₹217 crore and net profit of ₹7.78 crore for the September 2026 quarter.

Sudarshan Pharma (NSE: SUDARSHAN) closed at ₹29.90 on 20 Nov 2026. Its market capitalisation is ₹761 crore and it trades at 26.2 times earnings.

Share price
₹29.90 (20 Nov 2026)
Market cap
₹761 Cr (20 Nov 2026)
P/E
26.20 (20 Nov 2026)
Revenue
₹217 Cr (September 2026 quarter)
Net profit
₹8 Cr (September 2026 quarter)
ROCE
15.1% (FY26)
ROE
16.3% (FY26)
Book value
₹7.68 (FY26)
Dividend yield
0.00% (last 12 months to 20 Nov 2026)
52-week high / low
₹39.30 / ₹28.51 (20 Nov 2026)
Sector
Commodities
Industry
Specialty Chemicals
Symbol
NSE: SUDARSHAN

Incorporated in 2008, Sudarshan Pharma Industries Ltd manufactures API and Pharmaceutical Items. It also trades in Chemicals and Solvents

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.